UPDATED May 03, 2022
Companies that are potentially undervalued based on future cash flows and market ratios.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
M3VMeVis Medical Solutions | €33.40 | 1.8% | 1.2% | €60.8m | n/a | PE13.4x | n/a | 0% | ||
JTHGesundheitswelt Chiemgau | €344.00 | 5.5% | 32.3% | €25.8m | n/a | PE6.9x | n/a | 1.7% | ||
FREFresenius SE KGaA | €35.13 | 4.3% | -15.1% | €19.6b | €44.52 | PE10.8x | E8.7% | 2.6% | ||
NN6NanoRepro | €4.20 | -13.2% | -54.4% | €54.1m | n/a | PE2x | n/a | 11.9% | ||
FMEFresenius Medical Care KGaA | €58.00 | -2.7% | -12.2% | €17.0b | €67.64 | PE17.5x | E15.2% | 2.3% | ||
MEDMEDICLIN | €3.80 | 3.3% | -15.2% | €180.5m | €5.55 | PE19.6x | E21.4% | 0% | ||
HAEKHAEMATO | €21.80 | -4.8% | -25.3% | €114.0m | €44.50 | PE22.7x | E26.9% | 4.6% | ||
SYABSYNLAB | €14.28 | -0.8% | -28.6% | €3.2b | €23.03 | PE5.2x | E-22.6% | 2.3% |